Effects of liraglutide add-on to insulin therapy in patients with type 2 diabetes
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000030622
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Liraglutide induction by educational hospitalization of diabetes (2)Renal dysfunction (eGFR <30ml/min/1.73m2) (3)Steroid medication (4)Liver cirrhosis merger (5)Active Malignant neoplasm (6)Pregnant or lactating women (7)Decided as inappropriate for participating in this study by physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method